SEARCH

SEARCH BY CITATION

References

  • 1
    Szabo R, Wu Q, Dickson RB, Netzel-Arnett S, Antalis TM & Bugge TH (2003) Type II transmembrane serine proteases. Thromb Haemost 90, 185193.
  • 2
    Bugge TH, Antalis TM & Wu Q (2009) Type II transmembrane serine proteases. J Biol Chem 284, 2317723181.
  • 3
    Choi SY, Bertram S, Glowacka I, Park YW & Pohlmann S (2009) Type II transmembrane serine proteases in cancer and viral infections. Trends Mol Med 15, 303312.
  • 4
    Shimomura T, Denda K, Kitamura A, Kawaguchi T, Kito M, Kondo J, Kagaya S, Qin L, Takata H, Miyazawa K et al. (1997) Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem 272, 63706376.
  • 5
    Lin C-Y, Anders J, Johnson M & Dickson RB (1999) Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 274, 1823718242.
  • 6
    Tanaka H, Nagaike K, Takeda N, Itoh H, Kohama K, Fukushima T, Miyata S, Uchiyama S, Uchinokura S, Shimomura T et al. (2005) Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Mol Cell Biol 25, 56875698.
  • 7
    Fan B, Brennan J, Grant D, Peale F, Rangell L & Kirchhofer D (2007) Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth. Dev Biol 303, 222230.
  • 8
    Szabo R, Molinolo A, List K & Bugge TH (2007) Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene 26, 15461556.
  • 9
    Kirchhofer D, Peek M, Lipari T, Billeci K, Fan B & Moran P (2005) Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2. FEBS Lett 579, 19451950.
  • 10
    Herter S, Piper DE, Aaron W, Gabriele T, Cuter G, Cao P, Bhatt AS, Choe Y, Craik CS, Walker N et al. (2005) Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem J 390, 125136.
  • 11
    Kim DR, Sharmin S, Inoue M & Kido H (2001) Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung. Biochim Biophys Acta 1518, 204209.
  • 12
    Kido H & Okumura Y (2008) MSPL/TMPRSS13. Front Biosci 13, 754758.
  • 13
    Okumura Y, Takahashi E, Yano M, Ohuchi M, Daidoji T, Nakaya T, Bottcher E, Garten W, Klenk HD & Kido H (2010) Novel type II transmembrane serine proteases, MSPL and TMPRSS13, proteolytically activate membrane fusion activity of hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication. J Virol 84, 50895096.
  • 14
    Shimomura T, Denda K, Kawaguchi T, Matsumoto K, Miyazawa K & Kitamura N (1999) Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form. J Biochem 126, 821828.
  • 15
    Kawaguchi T, Qin L, Shimomura T, Kondo J, Matsumoto K, Denda K & Kitamura N (1997) Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J Biol Chem 272, 2755827564.
  • 16
    Marlor CM, Delaria KA, Davis G, Muller DK, Greve JM & Tamburini PP (1997) Identification and cloning of human placenta bikunin, a novel serine protease inhibitor containing two Kunitz domains. J Biol Chem 272, 1220212208.
  • 17
    Szabo R, Hobson JP, List K, Molinolo A, Lin C-Y & Bugge TH (2008) Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. J Biol Chem 283, 2949529504.
  • 18
    Lee SL, Dickson RB & Lin CY (2000) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 275, 3672036725.
  • 19
    Kondo A, Hirayama N, Sugito Y, Shono M, Tanaka T & Kitamura N (2008) Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation. J Biol Chem 283, 14281436.
  • 20
    Tsukada Y, Miyazawa K & Kitamura N (2001) High-intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2. J Biol Chem 276, 4096840976.
  • 21
    Hobson JP, Netzel-Arnett S, Szabo R, Rehault SM, Church FC, Strickland DK, Lawrence DA, Antalis TM & Bugge TH (2004) Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes. J Biol Chem 279, 4698146994.
  • 22
    Denda K, Shimomura T, Kawaguchi T, Miyazawa K & Kitamura N (2002) Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J Biol Chem 277, 1405314059.
  • 23
    Kojima K, Tsuzuki S, Fushiki T & Inouye K (2008) Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase. J Biol Chem 283, 24782487.
  • 24
    Shimomura T, Miyazawa K, Komiyama Y, Hiraoka H, Naka D, Morimoto Y & Kitamura N (1995) Activation of hepatocyte growth factor by two homologous proteases, blood coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 229, 257261.
  • 25
    Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Takahashi K et al. (1989) Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163, 967973.
  • 26
    Brinkmann V, Foroutan H, Sachs H, Weidner KM & Birchmeier W (1995) Hepatocyte growth factor/scatter factor induces a variety of tissue specific morphogenic programs in epithelial cells. J Cell Biol 131, 15731586.
  • 27
    Matsumoto K & Nakamura T (1996) Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119, 591600.
  • 28
    Miyazawa K, Shimomura T, Naka D & Kitamura N (1994) Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem 269, 89668970.
  • 29
    Naka D, Ishii T, Yoshiyama Y, Miyazawa K, Hara H, Hishida T & Kitamura N (1992) Activation of hepatocyte growth factor by proteolytic conversion of a single-chain form to a heterodimer. J Biol Chem 267, 2011420119.
  • 30
    Gak E, Taylor WG, Chan AM-L & Rubin JS (1992) Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity. FEBS Lett 311, 1721.
  • 31
    Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y & Kitamura N (1993) Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor – structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem 268, 1002410028.
  • 32
    Itoh H, Naganuma S, Takeda N, Miyata S, Uchinokura S, Fukushima T, Uchiyama S, Tanaka H, Nagaike K, Shimomura T et al. (2004) Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology 127, 14231435.
  • 33
    Peek M, Moran P, Mendoza N, Wichramasinghe D & Kichhofer D (2002) Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa. J Biol Chem 277, 4780447809.
  • 34
    Shimomura T, Ochiai M, Kondo J & Morimoto Y (1992) A novel protease obtained from FBS-containing culture supernatant, that processes single-chain form hepatocyte growth factor to two chain form in serum-free culture. Cytotechnology 8, 219229.
  • 35
    Kirchhofer D, Peek M, Li W, Stamos J, Eigenbrot C, Kadkhodayan S, Elliott JM, Corpuz T, Lazarus RA & Moran P (2003) Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J Biol Chem 278, 3634136349.